Evidence map›Paper›PMID 38956200›Full record

ArticleNature medicine2024

Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.

Nabil F Saba, Conor E Steuer, Asari Ekpenyong, Ashley McCook-Veal, Kelly Magliocca, Mihir Patel, Nicole C Schmitt, William Stokes, James E Bates, Soumon Rudra and 13 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Nabil F SabaDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA. nfsaba@emory.edu.ORCID http://orcid.org/0000-0003-4972-1477
Conor E SteuerDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Asari EkpenyongWinship Cancer Institute of Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-8515-1304
Ashley McCook-VealWinship Cancer Institute of Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0001-5368-4977
Kelly MaglioccaWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Mihir PatelWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Nicole C SchmittWinship Cancer Institute of Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-0571-3531
William StokesWinship Cancer Institute of Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-1616-7046
James E BatesWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Soumon RudraWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Jill RemickWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Mark McDonaldWinship Cancer Institute of Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0003-3021-9356
Marin AbousaudAstellas Pharma Global Development Inc., Astellas Pharma, Northbrook, USA.
Aik Choon TanDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Muhammad Zaki Hidayatullah FadlullahDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Ritu ChaudharyDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Jameel MuzaffarDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Kedar KirtaneDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Yuan LiuWinship Cancer Institute of Emory University, Atlanta, GA, USA.
Georgia Z ChenDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Dong M ShinDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Yong TengDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Christine H ChungDepartment of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0001-5199-4306

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38956200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.